Acute myocardial ischemia after high-dose therapy with BEAM regimen.
We describe a case of acute myocardial ischemia following carmustine treatment during the BEAM regimen. Despite this, full completion of the autologous peripheral stem-cell transplant was possible.
Genet
P
P
Department of Haematology, Hôpital Victor Dupouy, Argenteuil, France.
Pulik
M
M
Gallet
B
B
Lionnet
F
F
Jondeau
K
K
Touahri
T
T
Laribi
K
K
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D002330:Carmustine / Q000008:administration & dosage / Q000009:adverse effects*; D003561:Cytarabine / Q000008:administration & dosage; D018572:Disease-Free Survival; D005047:Etoposide / Q000008:administration & dosage; D005260:Female; D006801:Humans; D007119:Immunoblastic Lymphadenopathy / Q000150:complications / Q000628:therapy; D008558:Melphalan / Q000008:administration & dosage; D008875:Middle Aged; D017202:Myocardial Ischemia / Q000139:chemically induced*; D036102:Peripheral Blood Stem Cell Transplantation; D014182:Transplantation, Autologous
D003561:Cytarabine; D005047:Etoposide; D008558:Melphalan; D002330:Carmustine